(Q36696233)

15 August 2017

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin (English)

1 reference

15 August 2017

phase I clinical trial

0 references

0 references

1 reference

Matsumura Y

1

1 reference

15 August 2017

Hamaguchi T

2

1 reference

15 August 2017

Ura T

3

1 reference

15 August 2017

Muro K

4

1 reference

15 August 2017

Yamada Y

5

1 reference

15 August 2017

Shimada Y

6

1 reference

15 August 2017

Shirao K

7

1 reference

15 August 2017

Okusaka T

8

1 reference

15 August 2017

Ueno H

9

1 reference

15 August 2017

Ikeda M

10

1 reference

15 August 2017

Watanabe N

11

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

91

1 reference

15 August 2017

10

1 reference

15 August 2017

1775-1781

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602204

15 August 2017

0 references

cites work

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil).

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410050

Development of the polymer micelle carrier system for doxorubicin

5 September 2018

1 reference

12 December 2020

Pharmacokinetics of doxorubicin in sarcoma patients

1 reference

12 December 2020

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes

1 reference

12 December 2020

Accelerated titration designs for phase I clinical trials in oncology

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6602204

1 reference

release_zqiwzki4ofbcle4gi36kwzpoqm

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zqiwzki4ofbcle4gi36kwzpoqm

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

15477860

1 reference